Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H26O6 |
| Molecular Weight | 386.4382 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C=C(C=C1)[C@H]2OC[C@H]3[C@@H]2CO[C@H]3C4=CC(OC)=C(OC)C=C4
InChI
InChIKey=PEUUVVGQIVMSAW-WWLNLUSPSA-N
InChI=1S/C22H26O6/c1-23-17-7-5-13(9-19(17)25-3)21-15-11-28-22(16(15)12-27-21)14-6-8-18(24-2)20(10-14)26-4/h5-10,15-16,21-22H,11-12H2,1-4H3/t15-,16-,21-,22+/m0/s1
| Molecular Formula | C22H26O6 |
| Molecular Weight | 386.4382 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Epipinoresinol is an important component of the medicinal herb Eucommia ulmoides, which has a substantial reputation as an effective antihypertensive remedy. Epipinoresinol (EPR) belongs to the group
of furofuran-type lignans consisting of two phenylpropane units. (+)-epipinoresinol exhibited antiplatelet aggregation activity. It also exhibited inhibitory effects on nitric oxide production. Epipinoresinol possess antiproliferative activity.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006809 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24963714 |
39.5 µM [IC50] | ||
Target ID: CHEMBL3979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
49.5 µM [EC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
58.6 µM [EC50] | ||
Target ID: CHEMBL3559683 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
10.3 µM [EC50] | ||
Target ID: GO:0070527 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25555357 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Optimized conversion of antiproliferative lignans pinoresinol and epipinoresinol: Their simultaneous isolation and identification by centrifugal partition chromatography and high performance liquid chromatography. | 2017-05-01 |
|
| Lignans and aromatic glycosides from Piper wallichii and their antithrombotic activities. | 2015-03-13 |
|
| Phenolic constituents from Parakmeria yunnanensis and their anti-HIV-1 activity. | 2013-10 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24963714
Epipinoresinol inhibited LPS-induced NO production in macrophage RAW 264.7 cells with IC50 value of 39.5 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:38:49 GMT 2025
by
admin
on
Mon Mar 31 22:38:49 GMT 2025
|
| Record UNII |
NFK65X655A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7000209
Created by
admin on Mon Mar 31 22:38:49 GMT 2025 , Edited by admin on Mon Mar 31 22:38:49 GMT 2025
|
PRIMARY | |||
|
NFK65X655A
Created by
admin on Mon Mar 31 22:38:49 GMT 2025 , Edited by admin on Mon Mar 31 22:38:49 GMT 2025
|
PRIMARY | |||
|
60102-89-8
Created by
admin on Mon Mar 31 22:38:49 GMT 2025 , Edited by admin on Mon Mar 31 22:38:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
0.91 uM IC50 for PAF binding in rabbit blood.
|